• Company
• SK Bioscience, Investing 2.4 trillion won over 5 years
• by Kim, Jin-Gu Apr 30, 2023 09:46am

• Company
• Hanmi, sales and operating profits highest in 8 years
• by Chon, Seung-Hyun Apr 28, 2023 05:49am

• Company
• Dupixent attempts to expand its reimb to infants in KOR
• by Eo, Yun-Ho Apr 28, 2023 05:49am

• Policy
• Dual punishment for CSO rebate excluded from review
• by Lee, Jeong-Hwan Apr 28, 2023 05:49am

• Company
• Antidiabetic Tenelia market rises 67% with entry of generics
• by Kim, Jin-Gu Apr 27, 2023 05:43am

• Company
• Need strong cost control for biopharmaceuticals in 2nd half
• by Jung, Sae-Im Apr 27, 2023 05:43am

• Company
• Yuhan’s Q1 operating profit rose fourfold this year
• by Chon, Seung-Hyun Apr 27, 2023 05:43am

• Company
• GSK, cash equivalents of 250,000 won
• by Jung, Sae-Im Apr 27, 2023 05:41am

• Company
• GSK launches 90 cap pkg of Duodart for prostatic hyperplasia
• by Jung, Sae-Im Apr 27, 2023 05:40am

• Policy
• JW Pharma Hemlibra will be reimbursed starting in May
• by Lee, Tak-Sun Apr 25, 2023 05:56am